METASTATIC PANCREATIC CANCER
Clinical trials for METASTATIC PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a viagra drug help fight liver cancer? new trial tests unlikely combo
Disease control TerminatedThis phase 2 trial tested a combination of three drugs—nivolumab (an immunotherapy), tadalafil (commonly used for erectile dysfunction), and vancomycin (an antibiotic)—in adults with liver cancer or liver metastases from colorectal or pancreatic cancers that had not responded to …
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Pancreatic cancer drug trial halted after just two patients
Disease control TerminatedThis phase 2 trial aimed to see if the drug niraparib could shrink tumors in people with metastatic pancreatic cancer that has certain gene mutations. Only 2 patients were enrolled before the study was terminated early, so we don't have enough information to know if it works. The…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Experimental combo for tough pancreatic cancer shows early promise
Disease control TerminatedThis early-phase trial tested whether adding the experimental drug YL-13027 to standard chemotherapy (gemcitabine and nab-paclitaxel) is safe for people with advanced pancreatic cancer that no longer responds to treatment. Only 4 participants were enrolled before the study was st…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Experimental pancreatic cancer combo trial halted early
Disease control TerminatedThis early-phase study tested whether adding the experimental drug NIS793 to standard chemotherapy (FOLFIRINOX) could help people with metastatic pancreatic cancer. Only 4 people took part before the study was stopped. The goal was to find a safe dose and see if the combination c…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Weight-Loss drug trial for pancreatic cancer halted early
Symptom relief TerminatedThis study tested a drug called anamorelin to see if it could help prevent weight loss and improve appetite in people with advanced pancreatic cancer who were starting chemotherapy. The trial planned to include about 100 participants but was stopped early after only 4 people enro…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Lahey Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC